Use of critical pathways to improve efficiency: a cautionary tale
- PMID: 14626473
Use of critical pathways to improve efficiency: a cautionary tale
Abstract
Background: Critical pathways are healthcare management plans that specify patient goals and the sequence and timing of actions necessary to achieve these goals with optimal efficiency. More than 80% of hospitals in the United States use critical pathways for at least some of their patients. Unfortunately, critical pathway effectiveness in improving clinical efficiency is unclear.
Objectives: To assess whether critical pathways have been successful in reducing patient length of stay (LOS) and resource utilization in our tertiary-care academic medical center.
Study design: A before-and-after observational study using multivariate linear regression analyses.
Methods: We identified all critical pathways initiated in our medical center between 1993 and 1996 in which at least 50 adult patients would be evaluated in the year preceding and succeeding pathway implementation; 13 pathways satisfied these inclusion criteria. Using a before-and-after design, multivariate linear regression was used to evaluate each pathway's effect on average monthly LOS and resource utilization after adjusting for case mix and secular trends.
Results: Three of the 13 pathways were associated with a statistically significant immediate decrease in inpatient LOS: acute myocardial infarction (20.7% decrease; P = .001), cesarean section (14.6% decrease; P = .03), and kidney transplantation (24.5% decrease; P = .003). Only 1 pathway, percutaneous transluminal coronary angioplasty (PTCA), produced a statistically significant decrease in LOS slope (a decrease of 5.2% per month; P = .001). Two pathways were accompanied by a statistically significant immediate reduction in ancillary resource utilization: kidney transplantation (26.4% decrease; P = .001) and community-acquired pneumonia (21.8% decrease; P = .002). Only the PTCA pathway produced a statistically significant decrease in resource utilization slope during the 12-month follow-up period (a decrease of 8.4% per month; P < .001).
Conclusions: Although some pathways did reduce LOS or resource utilization or both, most pathways reduced neither. Because substantial resources must be expended on pathway development, implementation, and maintenance, future efforts should be placed on further evaluating the effectiveness of critical pathways and understanding the reasons behind their success or failure before additional resources are consumed for this management strategy.
Similar articles
-
Are critical pathways effective for reducing postoperative length of stay?Med Care. 2003 May;41(5):637-48. doi: 10.1097/01.MLR.0000062552.92534.BE. Med Care. 2003. PMID: 12719688
-
Mortality and morbidity after hip fracture: can evidence based clinical pathways make a difference?J Rheumatol. 2000 Sep;27(9):2227-31. J Rheumatol. 2000. PMID: 10990238
-
Critical pathways for postoperative care after simple congenital heart surgery.Am J Manag Care. 1999 Feb;5(2):185-92. Am J Manag Care. 1999. PMID: 10346514
-
Basic statistics for clinical pathway evaluation.Nurs Econ. 1998 May-Jun;16(3):125-31. Nurs Econ. 1998. PMID: 9748975 Review.
-
Design and validation of a critical pathway for hospital management of patients with severe traumatic brain injury.J Trauma. 2008 May;64(5):1327-41. doi: 10.1097/TA.0b013e3181469ebe. J Trauma. 2008. PMID: 18469658 Review.
Cited by
-
The association between clinical pathways and hospital length of stay: a case study.J Med Syst. 2007 Feb;31(1):79-83. doi: 10.1007/s10916-006-9045-9. J Med Syst. 2007. PMID: 17283925
-
The perceived and objectively measured effects of clinical pathways' implementation on medical care in China.PLoS One. 2018 May 7;13(5):e0196776. doi: 10.1371/journal.pone.0196776. eCollection 2018. PLoS One. 2018. PMID: 29734350 Free PMC article.
-
Hospital protocols and evidence-based therapies: the importance of integrating aldosterone blockade into the management of patients with post-acute myocardial infarction heart failure.Clin Cardiol. 2006 Jan;29(1):4-8. doi: 10.1002/clc.4960290103. Clin Cardiol. 2006. PMID: 16477770 Free PMC article. Review.
-
RarERN Path: a methodology towards the optimisation of patients' care pathways in rare and complex diseases developed within the European Reference Networks.Orphanet J Rare Dis. 2020 Dec 14;15(1):347. doi: 10.1186/s13023-020-01631-1. Orphanet J Rare Dis. 2020. PMID: 33317578 Free PMC article.
-
Development of an Efficient and Effective Clinical Pathway for Cesarean Section in West Sumatra (Indonesia).Clinicoecon Outcomes Res. 2024 May 30;16:461-469. doi: 10.2147/CEOR.S447249. eCollection 2024. Clinicoecon Outcomes Res. 2024. PMID: 38831920 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources